SK286389B6 - Deriváty polyhydroxypyrazínov, spôsob ich prípravy, liečivá obsahujúce tieto deriváty a ich použitie - Google Patents

Deriváty polyhydroxypyrazínov, spôsob ich prípravy, liečivá obsahujúce tieto deriváty a ich použitie Download PDF

Info

Publication number
SK286389B6
SK286389B6 SK976-2001A SK9762001A SK286389B6 SK 286389 B6 SK286389 B6 SK 286389B6 SK 9762001 A SK9762001 A SK 9762001A SK 286389 B6 SK286389 B6 SK 286389B6
Authority
SK
Slovakia
Prior art keywords
choh
group
cycloalk
alk
salts
Prior art date
Application number
SK976-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK9762001A3 (en
Inventor
Herv Bouchard
Alain Commeron
Original Assignee
Aventis Pharma S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S. A. filed Critical Aventis Pharma S. A.
Publication of SK9762001A3 publication Critical patent/SK9762001A3/sk
Publication of SK286389B6 publication Critical patent/SK286389B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK976-2001A 1999-01-11 2000-01-07 Deriváty polyhydroxypyrazínov, spôsob ich prípravy, liečivá obsahujúce tieto deriváty a ich použitie SK286389B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900186A FR2788274B1 (fr) 1999-01-11 1999-01-11 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2000/000026 WO2000042027A1 (fr) 1999-01-11 2000-01-07 Nouveaux derives de polyhydroxypyrazines, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
SK9762001A3 SK9762001A3 (en) 2001-12-03
SK286389B6 true SK286389B6 (sk) 2008-09-05

Family

ID=9540746

Family Applications (1)

Application Number Title Priority Date Filing Date
SK976-2001A SK286389B6 (sk) 1999-01-11 2000-01-07 Deriváty polyhydroxypyrazínov, spôsob ich prípravy, liečivá obsahujúce tieto deriváty a ich použitie

Country Status (24)

Country Link
US (1) US6818637B2 (zh)
EP (1) EP1140861B1 (zh)
JP (1) JP4516694B2 (zh)
KR (1) KR100648324B1 (zh)
CN (1) CN1145615C (zh)
AT (1) ATE244226T1 (zh)
AU (1) AU774627B2 (zh)
BR (1) BR0007449B1 (zh)
CA (1) CA2359463C (zh)
CZ (1) CZ301380B6 (zh)
DE (1) DE60003631T2 (zh)
DK (1) DK1140861T3 (zh)
EA (1) EA003550B1 (zh)
ES (1) ES2198273T3 (zh)
FR (1) FR2788274B1 (zh)
HU (1) HU228761B1 (zh)
IL (2) IL143945A0 (zh)
NO (1) NO320398B1 (zh)
NZ (1) NZ512911A (zh)
PL (1) PL200682B1 (zh)
PT (1) PT1140861E (zh)
SK (1) SK286389B6 (zh)
WO (1) WO2000042027A1 (zh)
ZA (1) ZA200105657B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425596C (zh) * 2006-03-29 2008-10-15 中国烟草总公司郑州烟草研究院 脱氧果糖嗪的制备方法
CN101697972B (zh) * 2009-11-16 2011-08-10 朱峰 新曲霉酸在制备抗肿瘤药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018813A1 (en) * 1995-11-22 1997-05-29 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments
FR2766185B1 (fr) * 1997-07-18 2001-06-15 Rhone Poulenc Rorer Sa Medicaments contenant en tant que principe actif au moins un derive substitue de polyhydroxylalkylpyrazines, les nouveaux derives polyhydroxylalkylpyrazines et leur preparation

Also Published As

Publication number Publication date
DE60003631D1 (de) 2003-08-07
IL143945A (en) 2006-04-10
AU3051500A (en) 2000-08-01
BR0007449B1 (pt) 2011-08-09
HU228761B1 (en) 2013-05-28
US6818637B2 (en) 2004-11-16
FR2788274B1 (fr) 2001-02-09
HUP0105104A2 (hu) 2002-07-29
CZ20012483A3 (cs) 2001-10-17
NZ512911A (en) 2003-10-31
ATE244226T1 (de) 2003-07-15
DK1140861T3 (da) 2003-10-20
HUP0105104A3 (en) 2002-09-30
CZ301380B6 (cs) 2010-02-03
DE60003631T2 (de) 2004-06-03
JP2002534513A (ja) 2002-10-15
BR0007449A (pt) 2001-10-16
CA2359463C (fr) 2009-09-15
EA003550B1 (ru) 2003-06-26
WO2000042027A1 (fr) 2000-07-20
NO20013416D0 (no) 2001-07-10
CN1145615C (zh) 2004-04-14
FR2788274A1 (fr) 2000-07-13
KR20010101456A (ko) 2001-11-14
ES2198273T3 (es) 2004-02-01
IL143945A0 (en) 2002-04-21
PL200682B1 (pl) 2009-01-30
ZA200105657B (en) 2002-10-10
EA200100767A1 (ru) 2001-12-24
CN1352638A (zh) 2002-06-05
PT1140861E (pt) 2003-11-28
EP1140861A1 (fr) 2001-10-10
SK9762001A3 (en) 2001-12-03
CA2359463A1 (fr) 2000-07-20
NO20013416L (no) 2001-09-06
KR100648324B1 (ko) 2006-11-23
EP1140861B1 (fr) 2003-07-02
US20020077324A1 (en) 2002-06-20
AU774627B2 (en) 2004-07-01
NO320398B1 (no) 2005-11-28
PL348768A1 (en) 2002-06-03
JP4516694B2 (ja) 2010-08-04

Similar Documents

Publication Publication Date Title
SK286389B6 (sk) Deriváty polyhydroxypyrazínov, spôsob ich prípravy, liečivá obsahujúce tieto deriváty a ich použitie
JP4443034B2 (ja) ポリヒドロキシアルキルピラジン誘導体、それらの製造およびそれらを含有する医薬品
MXPA00000437A (es) Polihidroxibutilpirazinas, su preparacion y medicamentos que las contienen.
SK452000A3 (en) Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them
JP4590099B2 (ja) ポリヒドロキシアルキルピラジン誘導体及びそれらの製造及びそれらを含有する薬剤
MXPA01006975A (en) Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
CZ2000119A3 (cs) Deriváty polyhydroxyalkylpyrazinu, způsob jejich přípravy a léčiva, která je obsahují
FR2766182A1 (fr) Medicaments contenant des derives de polyhydroxyalkylpyrazine, les nouveaux derives de polyhydroxyalkylpyrazine et leur preparation
CZ2001143A3 (cs) Léčiva obsahující deriváty polyhydroxyalkylpyrazinu, nové deriváty polyhydroxyalkylpyrazinu a způsob jejich přípravy

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150107